Gene · 344
Papers3,206
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,206
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome- and epigenome-wide studies of plasma protein biomarkers for Alzheimer's disease implicate TBCA and TREM2 in disease risk. | Alzheimers Dement (Amst) | 2022 | 35475137 | PubTator, text mining | PubMed |
| Multi-omic analysis reveals enriched pathways associated with COVID-19 and COVID-19 severity. | PLoS One | 2022 | 35468151 | PubTator, text mining | PubMed |
| Viruses as tools in gene therapy, vaccine development, and cancer treatment. | Arch Virol | 2022 | 35462594 | PubTator, text mining | PubMed |
| Whole-exome sequencing reveals damaging gene variants associated with hypoalphalipoproteinemia. | J Lipid Res | 2022 | 35460704 | PubTator, text mining | PubMed |
| Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL). | Int J Mol Sci | 2022 | 35457118 | PubTator, text mining | PubMed |
| Anorexia Nervosa Is Associated with a Shift to Pro-Atherogenic Low-Density Lipoprotein Subclasses. | Biomedicines | 2022 | 35453644 | PubTator, text mining | PubMed |
| Serum Proteomic Profile of Asthmatic Patients after Six Months of Benralizumab and Mepolizumab Treatment. | Biomedicines | 2022 | 35453511 | PubTator, text mining | PubMed |
| First Recombinant High-Density Lipoprotein Particles Administration in a Severe ICU COVID-19 Patient, a Multi-Omics Exploratory Investigation. | Biomedicines | 2022 | 35453504 | PubTator, text mining | PubMed |
| Biomarkers of Neonatal Sepsis: From Being Mere Numbers to Becoming Guiding Diagnostics. | Cureus | 2022 | 35449688 | PubTator, text mining | PubMed |
| Stroke Proteomics: From Discovery to Diagnostic and Therapeutic Applications. | Circ Res | 2022 | 35420912 | PubTator, text mining | PubMed |
| A stepwise data interpretation process for renal amyloidosis typing by LMD-MS. | BMC Nephrol | 2022 | 35418036 | PubTator, text mining | PubMed |
| Proteomic Profiling of Saliva and Tears in Radiated Head and Neck Cancer Patients as Compared to Primary Sjögren's Syndrome Patients. | Int J Mol Sci | 2022 | 35409074 | PubTator, text mining | PubMed |
| Molecular Biological and Clinical Understanding of the Statin Residual Cardiovascular Disease Risk and Peroxisome Proliferator-Activated Receptor Alpha Agonists and Ezetimibe for Its Treatment. | Int J Mol Sci | 2022 | 35408799 | PubTator, text mining | PubMed |
| The pro-apoptotic Bax gene modifies susceptibility to craniofacial dysmorphology following gastrulation-stage alcohol exposure. | Birth Defects Res | 2022 | 35396933 | PubTator, text mining | PubMed |
| Genetic variation and intestinal cholesterol absorption in humans: A systematic review and a gene network analysis. | Prog Lipid Res | 2022 | 35390434 | PubTator, text mining | PubMed |
| Single-cell transcriptomics of the ventral posterolateral nucleus-enriched thalamic regions from HSV-1-infected mice reveal a novel microglia/microglia-like transcriptional response. | J Neuroinflammation | 2022 | 35387656 | PubTator, text mining | PubMed |
| Current WHO recommendation to reduce free sugar intake from all sources to below 10% of daily energy intake for supporting overall health is not well supported by available evidence. | Am J Clin Nutr | 2022 | 35380611 | PubTator, text mining | PubMed |
| iTRAQ-Based Proteomic Analysis Reveals Potential Serum Biomarkers for Pediatric Non-Hodgkin's Lymphoma. | Front Oncol | 2022 | 35371990 | PubTator, text mining | PubMed |
| Efficacy and Mechanism of Buyang Huanwu Decoction in Patients With Ischemic Heart Failure: A Randomized, Double-Blind, Placebo-Controlled Trial Combined With Proteomic Analysis. | Front Pharmacol | 2022 | 35370712 | PubTator, text mining | PubMed |
| Editorial: Lipids and Inflammation in Health and Disease. | Front Cardiovasc Med | 2022 | 35369350 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/344/papers?page=28